-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Viking Therapeutics, Inc. quarterly and annual Return On Equity history and change rate from Q1 2018 to Q3 2025.
- Viking Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -29%, a 130% decline year-over-year.
- Viking Therapeutics, Inc. annual Return On Equity for 2024 was -12%, a 57% increase from 2023.
- Viking Therapeutics, Inc. annual Return On Equity for 2023 was -28%, a 35% increase from 2022.
- Viking Therapeutics, Inc. annual Return On Equity for 2022 was -43%, a 71% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)